Merck KGaA (MKGAF)
155.45
-0.79
(-0.51%)
USD |
OTCM |
Oct 05, 16:00
Merck Market Cap : 67.59B for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 05, 2026 | 67.59B |
| October 02, 2026 | 67.93B |
| October 01, 2026 | 65.09B |
| September 30, 2026 | 71.27B |
| September 29, 2026 | 71.28B |
| September 28, 2026 | 69.35B |
| September 25, 2026 | 69.33B |
| September 24, 2026 | 67.44B |
| September 23, 2026 | 65.48B |
| September 22, 2026 | 65.20B |
| September 21, 2026 | 66.83B |
| September 18, 2026 | 65.96B |
| September 17, 2026 | 65.36B |
| September 16, 2026 | 68.28B |
| September 15, 2026 | 66.05B |
| September 14, 2026 | 68.42B |
| September 11, 2026 | 67.05B |
| September 10, 2026 | 66.06B |
| September 09, 2026 | 68.35B |
| September 08, 2026 | 67.40B |
| September 04, 2026 | 69.18B |
| September 03, 2026 | 72.43B |
| September 02, 2026 | 71.18B |
| September 01, 2026 | 73.22B |
| August 31, 2026 | 70.43B |
| Date | Value |
|---|---|
| August 28, 2026 | 71.36B |
| August 27, 2026 | 68.76B |
| August 26, 2026 | 71.56B |
| August 25, 2026 | 71.30B |
| August 24, 2026 | 71.06B |
| August 21, 2026 | 70.96B |
| August 20, 2026 | 70.49B |
| August 19, 2026 | 71.09B |
| August 18, 2026 | 69.66B |
| August 17, 2026 | 68.80B |
| August 14, 2026 | 68.96B |
| August 13, 2026 | 70.65B |
| August 12, 2026 | 71.09B |
| August 11, 2026 | 71.09B |
| August 10, 2026 | 72.35B |
| August 07, 2026 | 72.96B |
| August 06, 2026 | 73.04B |
| August 05, 2026 | 73.78B |
| August 04, 2026 | 74.17B |
| August 03, 2026 | 71.74B |
| July 31, 2026 | 73.43B |
| July 30, 2026 | 73.53B |
| July 29, 2026 | 72.28B |
| July 28, 2026 | 72.83B |
| July 27, 2026 | 70.96B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bayer AG | 48.69B |
| Dermapharm Holding SE | 2.363B |
| AstraZeneca PLC | 491.86B |
| GSK Plc | 94.25B |
| Johnson & Johnson | 613.57B |
Market Cap Related Metrics
| PE Ratio | 24.43 |
| PS Ratio | 2.742 |
| Price to Book Value | 1.959 |
| Price to Free Cash Flow | 856.66 |
| Price | 155.45 |
| Earnings Yield | 4.09% |
| Operating PE Ratio | 13.93 |
| Normalized PE Ratio | 20.72 |